Elizabeth Higbee-Dempsey

Elizabeth Higbee-Dempsey

Auto-generated profile, based on publicly available information

Elizabeth Higbee-Dempsey

Developmental Therapeutics Core, Northwestern University, Evanston, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2022 in Science
Verified
Journal Article
Closed access
YCYeon Sik Choi
Yeon Sik Choi
HJHyoyoung Jeong
Hyoyoung Jeong
RYRose T. Yin
Rose T. Yin
RARaudel Avila
Raudel Avila
APAnna Pfenniger
Anna Pfenniger
JRJohn A. Rogers
John A. Rogers
Temporary postoperative cardiac pacing requires devices with percutaneous leads and external wired power and control systems. This hardware introduces risks for infection, limitations on patient mobility, and requirements for surgical extraction procedures. Bioresorbable pacemakers mitigate some of these disadvantages, but they demand pairing with external, wired systems and secondary mechanisms for control. We present a transient closed-loop system that combines a time-synchronized, wireless network of skin-integrated devices with an advanced bioresorbable pacemaker to control cardiac rhythms, track cardiopulmonary status, provide multihaptic feedback, and enable transient operation with minimal patient burden. The result provides a range of autonomous, rate-adaptive cardiac pacing capabilities, as demonstrated in rat, canine, and human heart studies. This work establishes an engineering framework for closed-loop temporary electrotherapy using wirelessly linked, body-integrated bioelectronic devices.

27 April 2023 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
WOWei Ouyang
Wei Ouyang
WLWei Lu
Wei Lu
YZYamin Zhang
Yamin Zhang
YLYiming Liu
Yiming Liu
JKJong Uk Kim
Jong Uk Kim
John A. RogersJohn A. Rogers
John A. Rogers

1 December 2018 in Progress in Polymer Science
Verified
Journal Article
Closed access
HXHaihua Xiao
Haihua Xiao
Lesan YanLesan Yan
Lesan Yan
EDElizabeth M. Dempsey
Elizabeth M. Dempsey
WSWantong Song
Wantong Song
Ruogu QiRuogu Qi
Ruogu Qi
XCXuesi Chen
Xuesi Chen

1 January 2014 in Kidney International
Verified
Journal Article
Open access
PDF file
MLManchang Liu
Manchang Liu
NRNarsa M. Reddy
Narsa M. Reddy
EHElizabeth M. Higbee
Elizabeth M. Higbee
HPHaranatha R. Potteti
Haranatha R. Potteti
SNSanjeev Noel
Sanjeev Noel
HRHamid Rabb
Hamid Rabb
Acute kidney injury (AKI) caused by ischemia–reperfusion is a major clinical problem in both native and transplanted kidneys. We had previously shown that deficiency of Nrf2, a potent bZIP transcription factor that binds to the antioxidant response element, enhances susceptibility to experimental ischemic AKI. Here we further explored the role of Nrf2 in AKI by amplifying Nrf2 activation in vivo and in vitro with the synthetic triterpenoid CDDO-imidazolide. Mice treated with CDDO-imidazolide and undergoing experimental bilateral ischemic AKI had improved survival and renal function. Treated mice had improved renal histology with a decrease in tubular injury, as well as a decrease in proinflammatory cytokine and chemokine production compared with vehicle-treated mice. In an exploration of protective mechanisms, we found an upregulation of Nrf2 target antioxidant genes in CDDO-imidazolide-treated mouse kidneys. Furthermore, Nrf2-deficient mice treated with CDDO-imidazolide had no significant improvement in mortality, renal function or histology, proinflammatory cytokine gene expression, and no significant increase in antioxidant gene expression. In vitro studies demonstrated that the renal epithelial cells were likely an important target of CDDO-imidazolide. Thus, activation of Nrf2 signaling with CDDO-imidazolide confers protection from AKI, and presents a new therapeutic opportunity for this common and serious condition.

30 May 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHexia Guo
Hexia Guo
Wubin BaiWubin Bai
Wubin Bai
WOWei Ouyang
Wei Ouyang
YLYihan Liu
Yihan Liu
CWChangsheng Wu
Changsheng Wu
John A. RogersJohn A. Rogers
John A. Rogers
Continuous, real-time monitoring of perfusion after microsurgical free tissue transfer or solid organ allotransplantation procedures can facilitate early diagnosis of and intervention for anastomotic thrombosis. Current technologies including Doppler systems, cutaneous O2-sensing probes, and fluorine magnetic resonance imaging methods are limited by their intermittent measurements, requirements for skilled personnel, indirect interfaces, and/or their tethered connections. This paper reports a wireless, miniaturized, minimally invasive near-infrared spectroscopic system designed for uninterrupted monitoring of local-tissue oxygenation. A bioresorbable barbed structure anchors the probe stably at implantation sites for a time period matched to the clinical need, with the ability for facile removal afterward. The probe connects to a skin-interfaced electronic module for wireless access to essential physiological parameters, including local tissue oxygenation, pulse oxygenation, and heart rate. In vitro tests and in vivo studies in porcine flap and kidney models demonstrate the ability of the system to continuously measure oxygenation with high accuracy and sensitivity.

8 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YZYamin Zhang
Yamin Zhang
FLFei Liu
Fei Liu
YZYuhe Zhang
Yuhe Zhang
JWJin Wang
Jin Wang
DDDominic D’andrea
Dominic D’andrea
JRJohn A. Rogers
John A. Rogers
Degradable polymer matrices and porous scaffolds provide powerful mechanisms for passive, sustained release of drugs relevant to the treatment of a broad range of diseases and conditions. Growing interest is in active control of pharmacokinetics tailored to the needs of the patient via programmable engineering platforms that include power sources, delivery mechanisms, communication hardware, and associated electronics, most typically in forms that require surgical extraction after a period of use. Here we report a light-controlled, self-powered technology that bypasses key disadvantages of these systems, in an overall design that is bioresorbable. Programmability relies on the use of an external light source to illuminate an implanted, wavelength-sensitive phototransistor to trigger a short circuit in an electrochemical cell structure that includes a metal gate valve as its anode. Consequent electrochemical corrosion eliminates the gate, thereby opening an underlying reservoir to release a dose of drugs by passive diffusion into surrounding tissue. A wavelength-division multiplexing strategy allows release to be programmed from any one or any arbitrary combination of a collection of reservoirs built into an integrated device. Studies of various bioresorbable electrode materials define the key considerations and guide optimized choices in designs. In vivo demonstrations of programmed release of lidocaine adjacent the sciatic nerves in rat models illustrate the functionality in the context of pain management, an essential aspect of patient care that could benefit from the results presented here.